Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06088290 |
|---|---|
| Brief Title: | Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma |
| First Submitted : | September 28, 2023 |
| First Submitted that Met QC Criteria : | October 16, 2023 |
| First Posted : | October 18, 2023 |
| Last Update Submitted that Met QC Criteria : | April 26, 2024 |
| Last Update Posted : | April 29, 2024 |